Highly Active Antiretroviral Therapy and Progressive Multifocal Leukoencephalopathy: Effects on Cerebrospinal Fluid Markers of JC Virus Replication and Immune Response
Citations Over TimeTop 10% of 2000 papers
Abstract
Cerebrospinal fluid (CSF) samples were examined from 7 patients infected with human immunodeficiency virus type 1 (HIV-1) who had progressive multifocal leukoencephalopathy (PML). Samples were obtained both before and after 35-365 days of highly active antiretroviral therapy (HAART). By polymerase chain reaction, JC virus (JCV) DNA was found in 6 of 7 patients at baseline but in only 1 patient after HAART. In contrast, in 25 historical control patients from whom sequential CSF specimens were obtained, no reversion from detectable to undetectable JCV DNA was observed. By use of enzyme-linked immunosorbent assay, intrathecal production of antibody to JCV-VP1 was shown in only 1 of 4 HAART recipients at baseline but in 5 of 5 patients after treatment. The neuroradiological picture improved or had stabilized in all patients after 12 months of HAART, and all were alive after a median of 646 days (range, 505-775 days). Prolonged survival after HAART for PML is associated with JCV clearance from CSF. JCV-specific humoral intrathecal immunity may play a role in this response.
Related Papers
- → Traffic of JC Virus from Sites of Initial Infection to the Brain: The Path to Progressive Multifocal Leukoencephalopathy(2002)136 cited
- → PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy(1995)96 cited
- → Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy(2023)7 cited
- → Progressive multifokale Leukoenzephalopathie (PML) bei chronisch lymphatischer Leukämie (CLL) Literaturübersicht und Fallbeschreibung(2002)12 cited
- → Seroepidemiology of the Human Polyomavirus JC in a Cohort of Italian Infants(2015)